Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2024 · first_quarter · Q1
Requesting funding and report language for Syringe Services Programs (SSPs) in the Infectious Diseases and the Opioid Epidemic program at the Centers for Disease Control and Prevention (CDC) in the Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill.
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Supported the introduction of the Reentry Act (H.R. 2400) in the House.
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
George Floyd Justice in Policing Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied the Senate to make improvements to the Justice in Policing Act (HR 1280), a federal policing bill. Lobbied on behalf of the FAIR Act(HR 2857) to end civil asset forfeiture. Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $120 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $120 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied the Senate to make improvements to the Justice in Policing Act (HR 1280), a federal policing bill. Lobbied on behalf of the FAIR Act(HR 2857) to end civil asset forfeiture. Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied the Senate to make improvements to the Justice in Policing Act (HR 1280), a federal policing bill. Lobbied on behalf of the FAIR Act(HR 2857) to end civil asset forfeiture. Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied the Senate to make improvements to the Justice in Policing Act (HR 1280), a federal policing bill. Lobbied on behalf of the FAIR Act(HR 2857) to end civil asset forfeiture. Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $120 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $120 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Mainstreaming Addiction Treatment Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
Mainstreaming Addiction Treatment Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Mainstreaming Addiction Treatment Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act
Mainstreaming Addiction Treatment Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
Comprehensive Addiction Resources Emergency Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
Comprehensive Addiction Resources Emergency Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act
Comprehensive Addiction Resources Emergency Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Comprehensive Addiction Resources Emergency Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Comprehensive Addiction Resources Emergency Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Comprehensive Addiction Resources Emergency Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
Comprehensive Addiction Resources Emergency Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
Comprehensive Addiction Resources Emergency Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act
Stopping Overdoses of Fentanyl Analogues Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
Stopping Overdoses of Fentanyl Analogues Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Stopping Overdoses of Fentanyl Analogues Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
Stopping Overdoses of Fentanyl Analogues Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Mainstreaming Addiction Treatment Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
Mainstreaming Addiction Treatment Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act
Mainstreaming Addiction Treatment Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
Mainstreaming Addiction Treatment Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
Mainstreaming Addiction Treatment Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act
Comprehensive Addiction Resources Emergency Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
Comprehensive Addiction Resources Emergency Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act
Stopping Overdoses of Fentanyl Analogues Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
Mainstreaming Addiction Treatment Act of 2019
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
S. 1764, CARERS Act, issues related to medical marijuana and ending federal marijuana prohibition. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
S 1689, Marijuana Justice Act, issues related to ending federal marijuana prohibition.
S. 1764, CARERS Act, issues related to medical marijuana and ending federal marijuana prohibition. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
Sentencing Reform and Corrections Act of 2017
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
Sentencing Reform and Corrections Act of 2017
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
Sentencing Reform and Corrections Act of 2017
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
Issues related to synthetic drugs Issues related to criminal justice and sentencing reform and re-entry Better Drive Act, HR 1952
Issues related to synthetic drugs Issues related to criminal justice and sentencing reform and re-entry Better Drive Act, HR 1952
S. 1764, CARERS Act, issues related to medical marijuana. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to overdose.
S 1689, Marijuana Justice Act, sssues related to ending federal marijuana prohibition.
Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. S 1689, Marijuana Justice Act, sssues related to ending federal marijuana prohibition.
Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. S 1689, Marijuana Justice Act, sssues related to ending federal marijuana prohibition.
S. 1764, CARERS Act, issues related to medical marijuana. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to overdose.
S. 1764, CARERS Act, issues related to medical marijuana. Issues related to synthetic drugs. Issues related to overdose.
S. 1764, CARERS Act, issues related to medical marijuana. Issues related to synthetic drugs. Issues related to overdose.
Dangerous Synthetic Drug Control Act of 2016
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Dangerous Synthetic Drug Control Act of 2016
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Dangerous Synthetic Drug Control Act of 2016
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Dangerous Synthetic Drug Control Act of 2016
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Dangerous Synthetic Drug Control Act of 2016
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Comprehensive Addiction and Recovery Act of 2016
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Comprehensive Addiction and Recovery Act of 2016
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Comprehensive Addiction and Recovery Act of 2016
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Comprehensive Addiction and Recovery Act of 2016
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Comprehensive Addiction and Recovery Act of 2016
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · fourth_quarter · Q4
Requesting $150 million in funding and report language for Syringe Services Programs (SSPs) in the Infectious Diseases and the Opioid Epidemic program at the Centers for Disease Control and Prevention (CDC) in the FY 2024 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill.
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · third_quarter · Q3
Requesting $150 million in funding and report language for Syringe Services Programs (SSPs) in the Infectious Diseases and the Opioid Epidemic program at the Centers for Disease Control and Prevention (CDC) in the FY 2024 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · second_quarter · Q2
Requesting $150 million in funding and report language for Syringe Services Programs (SSPs) in the Infectious Diseases and the Opioid Epidemic program at the Centers for Disease Control and Prevention (CDC) in the FY 2024 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · first_quarter · Q1
Requesting $150 million in funding and report language for Syringe Services Programs (SSPs) in the Infectious Diseases and the Opioid Epidemic program at the Centers for Disease Control and Prevention (CDC) in the FY 2024 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill.
Supported the introduction of the Reentry Act (H.R. 2400) in the House.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · second_quarter · 2A
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $69.5 million in appropriations for syringe service programs and other harm reduction tools/services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · fourth_quarter · Q4
Lobbied for appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Lobbied for $150 million in appropriations for syringe service programs and other harm reduction tools/services. Lobbied for the MEAL Act to lift the ban on people with drug convictions receiving SNAP/TANF benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · third_quarter · 3A
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Lobbied for $150 million in appropriations for syringe service programs and other harm reduction tools/services. Lobbied for the MEAL Act to lift the ban on people with drug convictions receiving SNAP/TANF benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · third_quarter · Q3
Lobbied for $150 million in appropriations for syringe service programs and other harm reduction tools/services.
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · second_quarter · Q2
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Lobbied for $150 million in appropriations for syringe service programs and other harm reduction tools/services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · first_quarter · Q1
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $69.5 million in appropriations for syringe service programs and other harm reduction tools/services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2021 · fourth_quarter · Q4
Lobbied for $69.5 million in appropriations for syringe service programs and other harm reduction tools/services.
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2021 · third_quarter · Q3
Lobbied for $120 million in appropriations for syringe service programs and other harm reduction tools/services.
Lobbied for $120 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2021 · second_quarter · Q2
Lobbied the Senate to make improvements to the Justice in Policing Act (HR 1280), a federal policing bill. Lobbied on behalf of the FAIR Act(HR 2857) to end civil asset forfeiture. Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $120 million in appropriations for syringe service programs and other harm reduction tools/services.
Lobbied for $120 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2021 · first_quarter · Q1
Lobbied for $120 million in appropriations for syringe service programs and other harm reduction tools/services.
Lobbied to improving Justice in Policing Act, a federal policing bill. Supported sentencing reform bills. Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions.
Lobbied for $120 million appropriations funding for syringe service providers and to lift the federal ban on syringes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2020 · fourth_quarter · Q4
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Advocated for funding harm reduction services in the Congressional budget in light of COVID-19 and high overdose rates.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2020 · third_quarter · Q3
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2020 · second_quarter · Q2
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2020 · first_quarter · Q1
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2019 · second_quarter · 2A
law enforcement reform
Drug overdose prevention, expanding access to drug treatment and harm reduction services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2019 · first_quarter · 1A
law enforcement reform
Drug overdose prevention, expanding access to drug treatment and harm reduction services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2019 · fourth_quarter · Q4
Funding for medication assisted treatment in jails and prisons; removal of a congressional rider barring Washington DC from taxing and regulating marijuana.
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2019 · third_quarter · Q3
overdose, drug policy and criminal justice funding
criminal justice reform
overdose issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2019 · second_quarter · Q2
overdose issues
criminal justice reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2019 · first_quarter · Q1
criminal justice reform
overdose issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2018 · fourth_quarter · Q4
HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2018 · third_quarter · Q3
HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2018 · second_quarter · Q2
HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2018 · first_quarter · Q1
S. 1764, CARERS Act, issues related to medical marijuana and ending federal marijuana prohibition. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
S 1689, Marijuana Justice Act, issues related to ending federal marijuana prohibition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2017 · first_quarter · 1A
Issues related to synthetic drugs Issues related to criminal justice and sentencing reform and re-entry Better Drive Act, HR 1952
Issues related to drug overdose Issues related to drug testing Issues related to medical marijuana
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2017 · fourth_quarter · Q4
S 1689, Marijuana Justice Act, sssues related to ending federal marijuana prohibition.
S. 1764, CARERS Act, issues related to medical marijuana. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to overdose.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2017 · first_quarter · Q1
Issues related to synthetic drugs Issues related to criminal justice and sentencing reform and re-entry Better Drive Act, HR 1952
Issues related to drug overdose Issues related to drug testing Issues related to medical marijuana
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2017 · third_quarter · Q3
Issues related to marijuana spending amendments. Issues related to LEAD (DOJ) funding.
Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. S 1689, Marijuana Justice Act, sssues related to ending federal marijuana prohibition.
S. 1764, CARERS Act, issues related to medical marijuana. Issues related to synthetic drugs. Issues related to overdose.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2017 · second_quarter · Q2
S. 1764, CARERS Act, issues related to medical marijuana. Issues related to synthetic drugs. Issues related to overdose.
Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. S 1689, Marijuana Justice Act, sssues related to ending federal marijuana prohibition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2016 · second_quarter · 2A
Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition.
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2016 · fourth_quarter · Q4
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2016 · third_quarter · Q3
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2016 · second_quarter · Q2
Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition.
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2016 · first_quarter · Q1
Smarter Sentencing Act, issues relating to drug sentencing. Recidivism Reduction and Public Safety Act, issues relating to drug sentencing. Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition. Issues related to Higher Education Act drug conviction student loan ban.
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2015 · fourth_quarter · Q4
Smarter Sentencing Act, issues relating to drug sentencing. Recidivism Reduction and Public Safety Act, issues relating to drug sentencing. Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition. Issues related to Higher Education Act drug conviction student loan ban.
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2015 · third_quarter · Q3
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.
Smarter Sentencing Act, issues relating to drug sentencing. Recidivism Reduction and Public Safety Act, issues relating to drug sentencing. Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition. Issues related to Higher Education Act drug conviction student loan ban.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2015 · second_quarter · Q2
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana.
Smarter Sentencing Act, issues relating to drug sentencing. Recidivism Reduction and Public Safety Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition. Issues related to Higher Education Act drug conviction student loan ban.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2015 · first_quarter · Q1
Smarter Sentencing Act, issues relating to drug sentencing. Recidivism Reduction and Public Safety Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition. Issues related to Higher Education Act drug conviction student loan ban.
Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2014 · fourth_quarter · Q4
S.2092, Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. S.2755, Overdose Prevention Act, issues related to overdose prevention.
H.R.83 - FY2015 Omnibus; Consolidated and Further Continuing Appropriations Act - issues related to D.C. and marijuana legalization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2014 · third_quarter · Q3
S.2092, Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. S.2755, Overdose Prevention Act, issues related to overdose prevention.
H.R.1523, Respect State Marijuana Laws Act of 2013, issues relating to legalizing marijuana. S.1410, Smarter Sentencing Act of 2014, issues relating to sentencing reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2014 · second_quarter · Q2
H.R.4169, S.O.S. Act, issues relating to overdose prevention. H.R.4288, Opioid Overdose Reduction Act of 2014, issues relating to overdose prevention. S.2092, Opioid Overdose Reduction Act of 2014, issues relating to overdose prevention. S.2755, A bill to prevent deaths occurring from drug overdoses, issues relating to overdose prevention
H2787, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2014, issues related to medical marijuana. H2787, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2014, issues related to DEA funding. S.1329, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2014, issues related to medical marijuana. H.R.2786, Financial Services and General Government Appropriations Act, 2014, issues related to marijuana and banking.H.R.2786, Financial Services and General Government Appropriations Act, 2014, issues related to marijuana and D.C. S. 1372, Department of State, Foreign Operations, and Related Programs Appropriations Act, Fiscal Year 2014, issues related to sentencing reform.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2014 · first_quarter · Q1
S. 4169, S.O.S. Act, issues relating to overdose prevention. Issues related to federal syringe funding ban..
H.R. 499, Ending Federal Marijuana Prohibition Act of 2013, issues related to legalizing marijuana. H.R. 1523, Respect State Marijuan Laws Act of 2013, issues relating to legalizing marijuana. S. 1410, Smarter Sentencing Act of 2014, issues relating to drug sentencing. S. 1675, Recidivism Reduction and Public Safety Act of 2014, issues relating to drug sentencing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2013 · fourth_quarter · Q4
H.R. 2642, the Federal Agriculture Reform and Risk Management Act of 2013, issues relating to SNAP and drug testing.
Issues related to drug overdoses. Issues related to federal syringe funding ban.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2013 · third_quarter · Q3
H.R. 2642, the Federal Agricutlre Reform and Risk Management Act of 2013, issues related to SNAP and drug testing
Issues related to drug overdoses; H.R. 689, States' Medical Marijuana Patient Protection Act, issues related to medical marijuana; Issues related to federal syringe funding ban
H.R. 499, Ending Federal Marijuana Prohibition Act of 2013, issues related to legalizing marijuana; H.R. 964, Respect States' and Citizens' Rights Act of 2013, issues related to legalizing marijuana; H.R. 1523, Respect STate Marijuana Laws Act of 2013, issues related to legalizing marijuana; S. 619, the Justice Safety Valve Act of 2013, issues related to mandatory minimum sentencing;S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act, issues related to immigation and drug policy; S. 1410, Smarter Sentencing Act of 2014, issues related to mandatory minimum sentencing.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2013 · second_quarter · Q2
Issues related to drug overdoses; H.R. 689, States' Medical Marijuana Patient Protection Act, issues related to medical marijuana; H.R. 784, States' Medical Marijuana Property Rights Protection Act, issues related to medical marijuana; H.R. 710, Truth in Trials Act, issues related to medical marijuana; Issues related to federal syringe funding ban;
H.R. 1947, the Federal Agriculture Reform and Risk Management Act (FARRM) of 2013, issues related to SNAP and drug testing, and issues related to legalizing hemp; H.R. 6083, the Federal Agriculture Reform and Risk Management Act (FARRM), issues related to SNAP and drug testing, and issues related to legalizing hemp; S.954, the Agriculture Reform, Food, and Jobs Act of 2013, issues related to legalizing hemp; H.R. 525, the Industrial Hemp Farming Act of 2013, issues relatedd to legalizing hemp; S. 359, the Industrial Hemp Farming Act of 2013, issues related to legalizing hemp;
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2013 · first_quarter · Q1
H.R. 499, Ending Federal Marijuana Prohibition Act of 2013, issues related to legalizing marijuana H.R. 964, Respect States' and Citizens' Rights Act of 2013, issues related to legalizing marijuana H.R. 1523, Respect State Marijuana Laws Act of 2013, issues related to legalizing marijuana H.R. 446, National Criminal Justice Commission Act of 2013, issues related to over-incarcerationS. 619, the Justice Safety Valve Act of 2013, issues related to mandatory minimum sentencing Issues relaed to BoP population and possible risk assessment legislation
Issues related to drug overdoses H.R. 689, States' Medical Marijuana Patient Protection Act, issues related to medical marijuanaH.R. 784, States' Medical Marijuana Property Rights Protection Act, issues related to medical marijuana H.R. 710, Truth in Trials Act, issues related to medical marijuana Issues related to federal syringe funding ban Issues related to medical marijuana and veterans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2012 · fourth_quarter · 4A
H.R. 6311, the Stop Overdose Stat Act, issues related to overdose and naloxone H.R. 1983, States' Medical Marijuana Patient Protection Act, issues related to medical marijuana H.R. 1984, Small Business Banking IMprovement Act of 2011, issues related to medical marijuana H.R. 1985, Small Business Tax Equity Act of 2011, issues related to medical marijuana
S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration. H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues related to legalizing marijuana. Issues related to appopriations for Byrne-Jag grants, COPS, drug courts, Second Chance Act funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2012 · fourth_quarter · Q4
S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues related to legalizing marijuana Issues related to appropriations for Byrne-Jag grants, COPS, drug courts, Second Chance Act funding
H.R. 6311, the Stop Overdose State Act, issues related to overdose and naloxone H.R. 1983, States' Medical Marijuana Patient Protection Act, issues related to medical marijuana H.R. 1984, Small Business Banking Improvement Act of 2011, issues related to medical marijuana H.R. 1985, Small Business Tax Equity Act of 2011, issues related to medical marijuana
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2012 · third_quarter · Q3
H.R. 6311, the Stop Overdose Stat Act, issues related to overdose and naloxone. H.R. 1983, States' Medical Marijuana Patient Protection Act, issues ralted to medical marijuana. H.R. 1984, Small Business Banking Improvement Act of 2011, issues related to medical marijuana. H.R. 19855, Small Business Tax Equity Act of 2011, issues related to medical marijuana.
S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues related to legalizing marijuana Issues related to appropriations for Byrne-Jag grants, COPS, drug courts, Second Chance Act funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2012 · third_quarter · Q3
S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration. H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana. Issues related to federal prison spending.
H.R. 1983, States' Medical Marijuana Patient Protection Act, issues related to medical marijuana. H.R. 1984, Small Business Banking Improvement Act of 2011, issues related to medical marijuana. H.R. 1985, Small Business Tax Equity Act of 2011, issues related to medical marijuana. H.R. 6311, S.O.S. Act, issues related to overdose prevention.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2012 · second_quarter · Q2
S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration H.R. 1254, Synthetic Drug Control Act of 2011, issues relating to Spice, "bath salts", and the scheduling system H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana. H.AMDT.1084 to H.R.5326, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2013, issues related to medical marijuana. S. 2323, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2013, issues related to medical marijuana. H.R. 6020, Financial Services and General Government Appropriations Act, 2013, issues related to medical marijuana. Issues related to Byrne Grant funding. Issues related to federal prison spending.
Issues related to overdose and naloxone. H.R. 1983, States' Medical Marijuana Patient Protection Act, issues related to medical marijuana. H.R. 1984, Small Business Banking Improvement Act of 2011, issues related to medcial marijuana. H.R. 1985, Small Business Tax Equity Act of 2011, issues related to medical marijuana Issues related to federal syringe funding ban.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2012 · first_quarter · Q1
Issues related to overdose and naloxone. H.R. 1983, States' Medical Marijuana Patient Protection Act, issues related to medical marijuana. H.R. 1985, Small Business Tax Equity Act of 2011, issues related to medical marijuana. H.R. 1984, Small Business Banking Improvement Act of 2011, issues related to medical marijuana Access to Substance Abuse Treatment Act of 2012
S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration. H.R. 313, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy law S. 1672, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy law H.R. 1254, Synthetic Drug Control Act of 2011, issues related to Spice, "bath salts", and the scheduling system H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2011 · fourth_quarter · Q4
H2055, Consolidated Appropriatons Act, issues relating to DC syringe ban. H2055, Consolidated Appropriations Act, issues relating to federal syringe ban H2055, Consolidated Appropriations Act, issues related to National Youth Anti-Drug Media Campaign H.R. 1983, States' Medical Marijuana Patient Protection Act, issues related to medical marijuana H.R. 1985, Small Business Tax Equity Act of 2011, issues related to medical marijuana H.R. 1984, Small Business Banknig Improvement Act of 2011, issues related to medical marijuana
H.R. 3765, Temporary Payroll Tax Cut Continuation Act of 2011, issues relating to drug testing of unemployment benefits applicants
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2011 · third_quarter · Q3
S. 306, National Criminal Justice Act of 2011, issues related to over-incarceration H.R. 313, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy law H.R. 1254, Synthetic Drug Control Act of 2011, issues related to Spice, "Bath Salts", and the scheduling system FY 2012 Commerce, Justice, Science Appropriations bill, issues related to funding for Byrne/JAG and COPS programs H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2011 · second_quarter · Q2
S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration H.R. 2242, Fairness in Cocaine Sentencing Act of 2011, issues related to crack/powder cocaine sentencing disparity H.R. 2316 , Fair Sentencing Claification Act of 2011, issues related to crack/powder cocaine sentencing disparity H.R. 2303, Major Drug Trafficking Prosecution Act of 2011, issues related to mandatory minimum sentencing FY 2012 Commerce, Justice, Science Appropriations bill, issues related to funding for Byrne/JAG and COPS programs H.R. 2306, Ending Federam Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2011 · first_quarter · Q1
H.R. 1, Full-Year Continuing Appropriations Act of 2011, issues related to federal syringe ban H.R. 1, Full-Year Continuing Appropriations Act of 2011, issues related to funding to National Youth Anti-Drug Media Campaign Issues related to overdose prevention
S. 306, National Criminal Justice Commission Act of 2011, issues related to over-incarceration H.R. 313, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy laws S. 409, Combating Dangerous Synthetic Stimulants Act of 2011, issues related to drug scheduling S. 605, Dangerous Synthetic Drug Control Act of 2011, issues related to drug scheduling S. 513, Saving Kids From Dangerous Drugs Act of 2011, issues related to medical marijuana H.R. 82, Drug Court Reauthorization Act, issues related to drug courts H.R. 1, Full-Year Continuing Appropriations Act of 2011, issues related to funding for Byrne/JAG and COPS programs H.R. 1, Full-Year Continuing Appropriations Act of 2011, issues related to civil asset forfeiture Issues relating to marijuana legalization and regulation
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2010 · fourth_quarter · Q4
H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses Issues relating to Appropriations for the National Youth Anti-Drug Media Campaign
S. 714, National Criminal Justice Commission Act of 2009, issues relating to over-incarceration Issues relating to the reauthorization of the Office of National Drug Control Policy S. 1516, Democracy Restoration Act of 2009, issues related to voting rights H.R. 3335, Democracy Restoration Act of 2009, issues related to voting rights H.R. 6548, Fair Sentencing Clarification Act of 2010, issues relating to crack/powder cocaine sentencing disparity H.R. 5231, Drug Trafficking Safe Harbor Elimination Act of 2010, issues related to drug conspiracy laws. H.R. 5748, End Racial Profiling Act of 2010, issues related to racial profiling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2010 · third_quarter · Q3
H.R. 3245, Fairness in Cocaine Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity S. 714, National Criminal Justice Commission Act of 2009, issues relating to over-incarceration S. 258, Saving Kids from Dangerous Drugs Act of 2010, issues relating to federal sentencing Issues relating to the reauthorization of the Office of National Drug Control Policy
H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses H.R. 5678, Universal Access to Methamphetamine Treatment Act of 2010, issues relating to treatment for methamphetamine misuse. Issues relating to Appropriations for the National Youth Anti-Drug Media Campaign
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2010 · second_quarter · 2A
H.R. 3245, Fairness in Cocaine Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity S. 1789, Fair Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity S. 714, National Criminal Justice Commission Act of 2009, issues relating to over-incarceration Issues relating to the reauthorization of the Office of National Drug Control Policy
H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses H.R. 5678, Universal Access to Methamphetamine Treatment Act of 2010, issues relating to treatment for methamphetamine misuse Issues relating to Appropriations for the National Youth Anti-Drug Media Campaign
Filing targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2010 · second_quarter · Q2
H.R. 3245, Fairness in Cocaine Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity S. 1789, Fair Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity S. 714, National Criminal Justice Commission Act of 2009, issues relating to over-incarceration Issues relating to the reauthorization of the Office of National Drug Control Policy
H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses H.R. 5678, Universal Access to Methamphetamine Treatment Act of 2010, issues relating to treatment for methamphetamine misuse Issues relating to Appropriations for the National Youth Anti-Drug Media Campaign
Filing targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2010 · first_quarter · Q1
H.R. 3245, Fairness in Cocaine Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity. S. 1789, Fair Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity S. 714, National Criminal Justice Commission Act of 2009, issues relating to over-incarceration Issues relating to reauthorization of Office of Natioanl Drug Control Policy
H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses. Issues relating to drug treatment for methamphetamine abuse.
H.R. 4872, Health Care and Education Reconciliation Act of 2010, issues relating to prohibition on students convicted of drug law offenses from receiving student loans and other education assistance.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2009 · fourth_quarter · Q4
H.R. 3288, 2010 Consolidated Appropriations Act, issues relating to federal syringe ban. H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2009 · third_quarter · Q3
H.R. 3245, Fairness in Cocaine Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity. S. 714, National Criminal Justice Commission Act of 2009, issues relating to over-incarceration. H.R. 1412, Justice Integrity Act of 2009, issues relating to racial disparities in the criminal justice system. S. 495, Justice Integrity Act of 2009, issues relating to racial disparities in the criminal justice system. Issues relating to taxing and regulating marijuana like alcohol.
H.R. 3221, Student Aid and Fiscal Responsibility Act of 2009, issues relating to prohibition on students convicted of drug law offenses from receiving student loans and other education assistance.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2009 · second_quarter · Q2
H.R. 179, Community AIDS and Hepatitis Prevention Act, issues relating to federal syringe ban. FY10 Labor-HHS-Education spending bill (no bill number), issues relating to federal syringe ban. H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses. Issues relating to drug treatment for methamphetamine abuse. H.R. 2943, Personal Use of Marijuana by Responsible Adults Act of 2009, issues relating to reduced penalties for marijuana possession. H.R. 3170, Financial Services and General Government Appropriations Act, 2010, issues relating to National Youth Anti-Drug Media Campaign.
H.R. 265, Drug Sentencing Reform and Cocaine Kingpin Trafficking Act of 2009, issues relating to the crack/powder sentencing disparity. H.R. 1459, Fairness in Cocaine Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity. H.R. 2178, Crack-Cocaine Equitable Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity. S. 714, National Criminal Justice Commission Act of 2009, issues relating to over-incarceration. Issues relating to Mexico / U.S. border violence. H.R. 1412, Justice Integrity Act of 2009, issues relating to racial disparities in the criminal justice system. S. 495, Justice Integrity Act of 2009, issues relating to racial disparities in the criminal justice system.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2009 · first_quarter · Q1
H.R. 179, Community AIDS and Hepatitis Prevention Act, issues relating to federal syringe ban. Issues relating to drug overdoses. Issues relating to drug treatment for methamphetamine abuse. Issues relating to TRICARE and Department of Defense health insurance coverage for drug treatment. Issues relating to student drug testing.
Issues relating to reauthorization of Office of National Drug Control Policy (ONDCP).
H.R. 265, Drug Sentencing Reform and Cocaine Kingpin Trafficking Act of 2009, issues relating to the crack/powder sentencing disparity. H.R. 1459, Fairness in Cocaine Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity. S. 714, National Criminal Justice Commission Act of 2009, issues relating to over-incarceration. Issues relating to restoring the right to vote to people with felony convictions. Issues relating to marijuana law reform. Issues relating to crack/powder sentencing disparity.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2008 · fourth_quarter · Q4
H.R. 5842, Medical Marijuana Patient Protection Act H.R. 6680, Community Aids and Hepatitis Prevention Act, issues relating to federal syringe ban. Issues relating to drug overdoses. Issues relating to drug treatment for methamphetamine abuse. Issues relating to student drug testing.
S. 1383, Drug Sentencing Reform Act of 2007, issues relating to the crack/powder sentencing disparity. S. 1711, Drug Sentencing Reform and Cocaine Kingpin Act, issues relating to the crack/powder sentencing disparity. Issues relating to the Byrne Justice Assistance Grant Program and H.R. 3546, To authroize the Edward Byrne Memorial Justice Assistance Grant Program at fiscal year 2006 levels through 2012. H.R. 4545, Drug Sentencing Reform and Cocaine Kingpin Trafficking Act of 2007, issues relating to the crack/powder sentencing disparity. S. 1685, Fairness in Drug Sentencing Act of 2007, issues relating to the crack/powder sentencing disparity. H.R. 5843, Act to Remove Federal Penalties for the Personal Use of Marijuana by Responsible Adults. Issues relating to restoring the right to vote to people with felony convictions.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2008 · third_quarter · Q3
H.R. 5842, Medical Marijuana Patient Protection Act. H.R. 6680, Community AIDS and Hepatitis Prevention Act, issues relating to federal syringe ban. Issues relating to drug overdoses.
Issues relating to the Byrne Justice Assistance Grant Program and H.R. 3546, To authorize the Edward Byrne Memorial Justice Assistance Grant Program at fiscal year 2006 levels through 2012. S. 1383, Drug Sentencing Reform Act of 2007, issues relating to the crack/powder sentencing disparity. S. 1711, Drug Sentencing Reform and Cocaine Kingpin Act, issues relating to the crack/powder sentencing disparity. H.R. 4545, Drug Sentencing Reform and Cocaine Kingpin Trafficking Act of 2007, issues relating to the crack/powder sentencing disparity. S. 1685, Fairness in Drug Sentencing Act of 2007, issues relating to the crack/powder sentencing disparity. S. 1211, Saving Kids from Dangerous Drugs Act of 2007, issues relating to medical marijuana. H.R. 5843, Act to Remove Federal Penalties for the Personal Use of Marijuana by Responsible Adults. Issues relating to restoring the right to vote.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2008 · second_quarter · Q2
S. 2767, To provide for judicial discretion regarding suspensions of student eligibility under section 484(r) of the Higher Education Act of 1965. Issues relating to the Higher Education Act Aid Elimination.
HR 5842, Medical Marijuana Patient Protection Act. HR 5843, Act to Remove Federal Penalties for the Personal Use of Marijuana by Responsible Adults. Issues relating to the federal syringe ban. Issues relating to health care coverage for methadone and buprenorphine treatments.
HR 3546, To authorize the Edward Byrne Memorial Justice Assistance Grant Program at fiscal year 2006 levels through 2012. S 1383, Drug Sentencing Reform Act of 2007, issues relating to the crack/powder sentencing disparity. Issues relating to restoring the right to vote. S 1711, Drug Sentencing Reform and Cocaine Kingpin Trafficking Act of 2007, issues relating to the crack/powder sentencing disparity. HR 4545, Drug Sentencing Reform and Cocaine Kingpin Trafficking Act of 2007, issues relating to the crack/powder sentencing disparity. S 1685, Fairness in Drug Sentencing Act of 2007, issues relating to the crack/powder sentencing disparity. HR 6021, To prohibit the purchase or lease of housing acquired using Federal loan or grant funds appropriated for the purchase and rehabilitation of foreclosed housing under the Neighborhood Stabilization Act of 2008 by any individual convicted under Federal or State law of a drug-dealing offense, a sex offense, or mortgage fraud.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2008 · first_quarter · 1A
Issues relating to the Higher Education Act Aid Elimination.
Issues and legislative policies relating to medical marijuana. Issues relating to the federal syringe ban. Issues relating to overdose prevention. Issues relating to the treatment of methamphetamine addicts.
S 1383, Drug Sentencing Reform Act of 2007, provisions relating to the crack/powder sentencing disparity. S 1711, Drug Sentencing Reform and Cocaine Kingpin Trafficking Act of 2007, provisions relating to the crack/powder sentencing disparity. HR 4545, Drug Sentencing Reform and Cocaine Kingpin Trafficking Act of 2007, provisions relating to the crack/powder sentencing disparity. S. 1685, Fairness in Drug Sentencing Act of 2007, provisions relating to the crack/powder sentencing disparity. Issues relating to treatment of methamphetamine addicts. Issues relating to medical marijuana. Issues relating to the federal syringe ban.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2008 · first_quarter · 1A
Crack/powder cocaine sentencing reform, HEA Aid Elimination Penalty, DC syringe ban, federal syringe ban
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2007 · year_end · YY
HR 3043, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008. S. 1710, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008, provisions relating to supervised injection. Issues relating to the DC syringe ban. Issues relating to overdose prevention.
S 1383, Drug Sentencing Reform Act of 2007, issues relating to the crack/powder sentencing disparity. S 1711, Drug Sentencing Reform and Cocaine Kingpin Trafficking Act of 2007, issues relating to the crack/powder sentencing disparity. HR 4545, Drug Sentencing Reform and Cocaine Kingpin Trafficking Act of 2007, issues relating to the crack/powder sentencing disparity. S. 1710, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill, 2008. H.R. 3093, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2008, provisions relating to medical marijuana. S. 1685, Fairness in Drug Sentencing Act or 2007, issues relating to the crack/powder sentencing disparity. Issues relating to methamphetamine. Issues relating to the HEA Aid Elimination Penalty.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Advocated for funding harm reduction services in the Congressional budget in light of COVID-19 and high overdose rates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for medication assisted treatment in jails and prisons; removal of a congressional rider barring Washington DC from taxing and regulating marijuana.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for medication assisted treatment in jails and prisons; removal of a congressional rider barring Washington DC from taxing and regulating marijuana.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1523, Respect State Marijuana Laws Act of 2013, issues relating to legalizing marijuana. S.1410, Smarter Sentencing Act of 2014, issues relating to sentencing reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 499, Ending Federal Marijuana Prohibition Act of 2013, issues related to legalizing marijuana; H.R. 964, Respect States' and Citizens' Rights Act of 2013, issues related to legalizing marijuana; H.R. 1523, Respect State Marijuana Laws Act of 2013, issues related to legalizing marijuana; H.R. 446, National Criminal Justice Commission Act of 2013, issues related to over-incarceration; S. 619, the Justice Safety Valve Act of 2013, issues related to mandatory minimum sentencing; H.R. 2656, Public Safety Enhancement Act of 2013, issues relaed to BoP population and risk assessment; H.R. 2652, Marijuana Businesses Access to Banking Act of 2013, issues related to marijuana and banking; H.R. 784, States' Medical Marijuana Property Rights Protection Act, issues related to marijuana and asset forfeiture; S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act, issues related to immigration and drug policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 3240, Agriculture Reform, Food, and Jobs Act of 2012, issues related to drug offenders and TANF. H.R. 6083, Federal Agriculture REform and Risk Management of 2012, issues related to drug offenders and TANF. S. 3602, Food Stamp Restoration Act of 2012, issues related to drug offenders and TANF.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 306, National Criminal Justice Act of 2011, issues related to over-incarceration H.R. 313, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy law S. 1672, Drug Trafficking Safe Harbor Elimination Act of 2011, issues related to drug conspiracy law H.R. 1254, Synthetic Drug Control Act of 2011, issues related to Spice, "Bath Salts", and the scheduling system H.R. 2306, Ending Federal Marijuana Prohibition Act of 2011, issues relating to legalizing marijuana.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY10 Labor-HHS-Education spending bill, issues relating to federal syringe ban. H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses. H.R. 2943, Personal Use of Marijuana by Responsible Adults Act of 2009, issues relating to reduced penalties for marijuana possession.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 3170, Financial Services and General Government Appropriations Act, 2010, issues relating to prohibition on medical marijuana in Washington, DC.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE